Bile salt receptor TGR5 is highly expressed in esophageal adenocarcinoma and precancerous lesions with significantly worse overall survival and gender differences

Bile salt receptor TGR5 is highly expressed in esophageal adenocarcinoma and precancerous lesions with significantly worse overall survival and gender differences

Chunhong Pang,1,2 Amy LaLonde,3 Tony E Godfrey,4 Jianwen Que,5,6 Jun Sun,7 Tong Tong Wu,3 Zhongren Zhou2 1Department of Pathology, China-Japan Friendship Hospital, 2Department of Pathology and Laboratory Medicine, 3Department of Biostatistics and Computational Biology, University of Rochester, Roche...

Full description

Bibliographic Details
Main Authors:	Pang CH, LaLonde A, Godfrey TE, Que J, Sun J, Wu TT, Zhou ZR
Format:	Article
Language:	English
Published:	Dove Medical Press 2017-02-01
Series:	Clinical and Experimental Gastroenterology
Subjects:	esophageal carcinoma Barrett's esophagus The G-protein coupled bile acid receptor amplification
Online Access:	https://www.dovepress.com/bile-salt-receptor-tgr5-is-highly-expressed-in-esophageal-adenocarcino-peer-reviewed-article-CEG

Similar Items

Current and Future Use of Esophageal Capsule Endoscopy
by: Junseok Park, et al.
Published: (2018-07-01)

Barrett's esophagus and eosinophilic esophagitis in a young pediatric patient with esophageal atresia
by: Li-Zsa Tan, et al.
Published: (2015-07-01)

Diagnosis and Management of Barrett’s Esophagus, Dysplasia and Early Esophageal Adenocarcinoma: Focusing on American and European Guidelines
by: Ah Young Yoo, et al.
Published: (2019-07-01)

Early diagnostic potential of APC hypermethylation in esophageal cancer
by: Wang B, et al.
Published: (2018-02-01)

Esophageal Adenocarcinoma Arising from Barrett's Epithelium in Taiwan
by: Chia-Hung Tu, et al.
Published: (2007-08-01)

Current status and future perspectives on the etiology of esophageal adenocarcinoma
by: Aaron P. Thrift, et al.
Published: (2012-02-01)

Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma
by: Anna M. J. van Nistelrooij, et al.
Published: (2015-01-01)

Prevention Strategies for Esophageal Cancer—An Expert Review
by: Elisa Marabotto, et al.
Published: (2021-05-01)

Indomethacin-Induced Apoptosis in Esophageal Adenocarcinoma Cells Involves Upregulation of Bax and Translocation of Mitochondrial Cytochrome C Independent of COX-2 Expression
by: Sanjeev Aggarwal, et al.
Published: (2000-07-01)

Toll-like receptors in esophageal cancer
by: Joonas H Kauppila, et al.
Published: (2014-05-01)

Impact of laparoscopic nissen fundoplication on non-Complicated Barrett′s esophagus
by: Ashraf A Mohamed, et al.
Published: (2011-01-01)

Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples
by: Anna M. J. van Nistelrooij, et al.
Published: (2017-04-01)

Proton Pump Inhibitors (PPIs): The culprit for Barrett’s esophagus?
by: Omran eAlsalahi, et al.
Published: (2015-01-01)

Genomic and Transcriptomic Characteristics of Esophageal Adenocarcinoma
by: Sascha Hoppe, et al.
Published: (2021-08-01)

Genome-wide tracts of homozygosity and exome analyses reveal repetitive elements with Barrets esophagus/esophageal adenocarcinoma risk
by: Visanu Wanchai, et al.
Published: (2019-03-01)

Urinary metabolomic signature of esophageal cancer and Barrett’s esophagus
by: Davis Vanessa W, et al.
Published: (2012-12-01)

Epidemiologic trends and geographic distribution of esophageal cancer in Canada: A national population‐based study
by: Leila Cattelan, et al.
Published: (2020-01-01)

Barrett’s esophagus and esophageal adenocarcinoma: biomarkers of proliferation, apoptosis, autophagy and angiogenesis
by: E. S. Petenyova, et al.
Published: (2021-01-01)

Prevalence and modern aspects of the treatment of patients with Barrett’s esophagus
by: V. V. Tsukanov, et al.
Published: (2018-10-01)

Buried Barrett’s Esophagus with High-Grade Dysplasia after Radiofrequency Ablation
by: Joana Castela, et al.
Published: (2019-05-01)

Interactive decision support for esophageal adenocarcinoma screening and surveillance
by: Thomas L. Vaughan, et al.
Published: (2019-06-01)

DINAMIC SCREENING OF PRECANCEROUS ESOPHAGUS USING MOLECULAR GENETIC ANALYSIS
by: V. V. Anishchenko, et al.
Published: (2020-12-01)

Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma
by: Jessie A. Elliott, et al.
Published: (2021-03-01)

Immunohistochemical expression analysis of MMP-1, TIMP-2 and p53 in Barrett’s esophagus, dysplasia and esophageal adenocarcinoma
by: Alejandro García-Varona, et al.
Published: (2021-05-01)

Treatment of long-segment Barrett’s adenocarcinoma by complete circular endoscopic submucosal dissection: a case report
by: Miki Kaneko, et al.
Published: (2018-01-01)

Modern aspects of treatment of hiatal hernia and its main complications
by: A. Yu. Usenko, et al.
Published: (2021-04-01)

Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett’s esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC)
by: Candyce Hamel, et al.
Published: (2020-01-01)

Prevention of Barrett's metaplasia in a human model of duodenogastro-oesophageal reflux
by: Richard J. Cade, et al.
Published: (2013-09-01)

Relationship between time-varying status of reflux esophagitis and Helicobacter pylori and progression to long-segment Barrett’s esophagus: time-dependent Cox proportional-hazards analysis
by: Genki Usui, et al.
Published: (2020-08-01)

The Impact of Artificial Intelligence in the Endoscopic Assessment of Premalignant and Malignant Esophageal Lesions: Present and Future
by: Daniela Cornelia Lazăr, et al.
Published: (2020-07-01)

Melatonin in Prevention of the Sequence from Reflux Esophagitis to Barrett’s Esophagus and Esophageal Adenocarcinoma: Experimental and Clinical Perspectives
by: Jolanta Majka, et al.
Published: (2018-07-01)

Lifestyle interventions can reduce the risk of Barrett’s esophagus: a systematic review and meta‐analysis of 62 studies involving 250,157 participants
by: Zhanwei Zhao, et al.
Published: (2021-08-01)

Successful Treatment of an Early Barrett’s Adenocarcinoma in a High-Risk Patient with Portal Hypertension: The “Band and Leave” Strategy
by: Miguel Fraile-López, et al.
Published: (2020-12-01)

Esophagectomy with gastroplasty in advanced megaesophagus: late results of omeprazole use
by: Celso de Castro Pochini, et al.

Evaluation of p53 protein expression in Barrett esophagus
by: Mahathi Krothapalli, et al.
Published: (2018-01-01)

Esófago de Barret en Pediatría: revisión de la literatura a propósito de un caso
by: Carlos Tori Tori, et al.
Published: (1998-01-01)

Taking the Next Steps in Endoscopic Visual Assessment of Barrett’s Esophagus: A Pilot Study
by: Chis R, et al.
Published: (2021-04-01)

THE REAL PREVALENCE OF EROSIVE ESOPHAGITIS AND BARRETT'S ESOPHAGUS IN SYSTEMIC SCLERODERMA: DATA FROM 12-MONTHS PROSPECTIVE STUDY
by: Andrey Evgenievich Karateev, et al.
Published: (2012-10-01)

Nrf2/Keap1-Pathway Activation and Reduced Susceptibility to Chemotherapy Treatment by Acidification in Esophageal Adenocarcinoma Cells
by: Lucie Storz, et al.
Published: (2021-06-01)

Detection of LINE-1 hypomethylation in cfDNA of Esophageal Adenocarcinoma Patients
by: Elisa Boldrin, et al.
Published: (2020-02-01)